| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043048A1 Treating protein-containing liquids |
| 07/27/2000 | WO2000043042A1 Parenteral metolazone formulations |
| 07/27/2000 | WO2000043041A1 Medicinal compositions with improved oral absorption |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000043034A2 Monodisperse hexameric acylated insulin analog formulations |
| 07/27/2000 | WO2000043033A1 CHAPERONIN 10 AND β-INTERFERON THERAPY OF MULTIPLE SCLEROSIS |
| 07/27/2000 | WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | WO2000043015A1 Eye drops |
| 07/27/2000 | WO2000042998A1 Multiparticulate bisoprolol formulation |
| 07/27/2000 | WO2000042997A1 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds |
| 07/27/2000 | WO2000042993A2 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
| 07/27/2000 | WO2000042992A2 Compositions and methods for mucosal delivery |
| 07/27/2000 | WO2000042991A1 Inorganic shaped bodies and methods for their production and use |
| 07/27/2000 | WO2000042990A1 Liposome formulations |
| 07/27/2000 | WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/27/2000 | WO2000042988A1 Method of identifying and treating inflamed tissue |
| 07/27/2000 | WO2000042987A2 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 07/27/2000 | WO2000042986A2 Artificial lacrimal fluid in gel form |
| 07/27/2000 | WO2000042983A1 A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating |
| 07/27/2000 | WO2000042959A1 Compact dosage unit for buccal administration of a pharmacologically active agent |
| 07/27/2000 | WO2000042955A1 Drug dosage unit for buccal administration of steroidal active agents |
| 07/27/2000 | WO2000042942A2 Buccal drug delivery system for use in male contraception |
| 07/27/2000 | WO2000042861A1 Chewing gum with dental health benefits employing calcium lactate |
| 07/27/2000 | WO2000042849A1 COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR AND SULFOBUTYLETHER-7-β-CYCLODEXTRIN OR 2-HYDROXYPROPYL-β-CYCLODEXTRIN AND METHOD |
| 07/27/2000 | WO2000042848A1 Medicinal composition and its process of preparation |
| 07/27/2000 | WO2000042846A1 Process for producing granules |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | WO2000025756A3 Medicament for topical treatment of inflammatory intestinal diseases |
| 07/27/2000 | WO2000025723A3 Methods and compositions for the prevention of tolerance to medications |
| 07/27/2000 | WO2000023592A3 Minimal promoters and uses thereof |
| 07/27/2000 | WO2000023086A3 Buffered compositions for dialysis |
| 07/27/2000 | WO2000023068A3 Fumaric acid microtablets |
| 07/27/2000 | WO2000013662A8 Medicated chewing gum delivery system for nicotine |
| 07/27/2000 | WO2000001321A9 Methods and compositions for producing a cooling effect in tissues |
| 07/27/2000 | WO2000000221A9 Water soluble dry compositions |
| 07/27/2000 | WO1999009149A9 Three-dimensional polymer matrices |
| 07/27/2000 | DE19926890C1 Use of highly fluorinated oligomeric alkanes in ophthalmology, especially as vitreous humor substitutes, retinal tamponade materials, liquid implants, tear fluid substitutes and drug carriers |
| 07/27/2000 | DE19902724A1 Microcapsules, e.g. useful as filtration and chromatography media, comprise intact macroporous pollen exine or sporoderm |
| 07/27/2000 | CA2361175A1 A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating |
| 07/27/2000 | CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | CA2361122A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | CA2360066A1 A pharmaceutical composition containing a compound having a phenolic hydroxyl group with coloring change being controlled |
| 07/27/2000 | CA2359709A1 Multiparticulate bisoprolol formulation |
| 07/27/2000 | CA2359641A1 Chewing gum with dental health benefits employing calcium lactate |
| 07/27/2000 | CA2359587A1 Compact dosage unit for buccal administration of steroidal active agent |
| 07/27/2000 | CA2359582A1 Compact dosage unit for buccal administration of a pharmacologically active agent |
| 07/27/2000 | CA2359483A1 Process for producing granules |
| 07/27/2000 | CA2359482A1 Organoprotective solutions |
| 07/27/2000 | CA2358971A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358524A1 Compositions and methods for mucosal delivery |
| 07/27/2000 | CA2358474A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/26/2000 | EP1022028A1 Sustained-release oral preparation |
| 07/26/2000 | EP1022025A2 Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron |
| 07/26/2000 | EP1022021A1 Quickly soluble solid preparations |
| 07/26/2000 | EP1022020A2 Sustained-release preparation |
| 07/26/2000 | EP1022019A1 Suppository composition |
| 07/26/2000 | EP1022017A2 Cosmetic or pharmaceutical compositions for topical administration with improved stability |
| 07/26/2000 | EP1021241A1 Method for producing a powder product from a liquid substance or mixture of substances |
| 07/26/2000 | EP1021204A2 Bioadhesive compositions and methods for topical administration of active agents |
| 07/26/2000 | EP1021203A2 Delivery system |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP1021192A1 Dexamethasone gel |
| 07/26/2000 | EP1021184A1 Use of flunarizine for the topical treatment of glaucoma |
| 07/26/2000 | EP1021180A1 Mixed cyanoacrylate ester compositions |
| 07/26/2000 | EP1021172A1 Dosage form for aerosol administration |
| 07/26/2000 | EP1021171A1 Delayed total release gastrointestinal drug delivery system |
| 07/26/2000 | EP1021170A1 Marking of orally ingested products |
| 07/26/2000 | EP1021169A1 Active agent transport systems |
| 07/26/2000 | EP1021168A1 Micro-particulate and nano-particulate polymeric delivery system |
| 07/26/2000 | EP1021167A1 High and low load formulations of igf-i in multivesicular liposomes |
| 07/26/2000 | EP1021165A1 Bioerodable polymeric adhesives for tissue repair |
| 07/26/2000 | EP1021155A1 Water dispersible perfluoroether polymer encapsulates |
| 07/26/2000 | EP1021148A1 Composition and method for acceleration of wound and burn healing |
| 07/26/2000 | EP1021137A1 Drug delivery system |
| 07/26/2000 | EP1021087A1 Serotonin containing formulation for oral administration and method of use |
| 07/26/2000 | EP1021084A1 Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 07/26/2000 | EP0930936B1 Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
| 07/26/2000 | EP0822808B1 Composite with sodium starch glycolate as a support material and products thereof |
| 07/26/2000 | EP0759775B1 Ifn-beta liquid formulations |
| 07/26/2000 | EP0755253B1 Intranasal antimigraine composition |
| 07/26/2000 | EP0576522B1 A single dose vaccination system |
| 07/26/2000 | CN2388936Y Improved hot medicinal paste |
| 07/26/2000 | CN1261362A Omeprazole sodium salt |
| 07/26/2000 | CN1261287A Pharmaceutical formulations containing voriconazole |
| 07/26/2000 | CN1261279A Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 07/26/2000 | CN1261273A Delayed-release dosage forms of sertraline |
| 07/26/2000 | CN1261271A Stable pharmaceutical administration forms of peptides, proteins and nucleic acids |
| 07/26/2000 | CN1261268A Shellac-containing cosmetic product |
| 07/26/2000 | CN1261000A Medical oxygen-enriched liquid and oxygen-dissolving apparatus |
| 07/26/2000 | CN1260998A Recombination adenovirus and its application in tumor treatment |
| 07/26/2000 | CN1260985A Chinese patent medicine for treating gastroptosis |
| 07/26/2000 | CN1260982A Exterior-applied antalgesic Chinese medicine 'Rudijinniu' |
| 07/26/2000 | CN1260980A Oral-applied medicine for curing impotence and preparing process thereof |
| 07/26/2000 | CN1054855C Non-reducing oligosaccharide and its production and use |
| 07/26/2000 | CN1054767C Pharmaceutical preparation for treatment of leukoderma |
| 07/26/2000 | CN1054766C Oral liquor for curing and regulating heart spleen and kidney functions |
| 07/26/2000 | CN1054764C Zhuieng tougu plaster for dissipating wind and removing dampness |